Clinical Documentation

    How to Evaluate AI Clinical Documentation Before Buying

    Written for: Clinical directors, QA leaders, and owners evaluating AI documentation features.

    Every vendor now claims AI documentation. The differences are in the review workflow, the audit trail, and what is actually shipping versus promised. Here is how to tell them apart.

    Questions that separate real features from demos

    • Show me the review step: where does the clinician edit and approve the AI draft?
    • Is the AI feature generally available, or a pilot or roadmap item?
    • What audit trail exists between the AI draft and the signed note?
    • Where is patient data processed, and is it used to train models?
    • What happens to the draft if the clinician rejects it?

    Red flags

    • A demo that shows drafting but never the clinician review and approval step.
    • Vague answers about whether the feature is shipping today.
    • No audit trail between the AI suggestion and the final signed note.
    • Claims of time savings with no explanation of how they were measured.

    How DSL approaches it

    DSL's AI-assisted documentation drafts notes from the clinician's voice input, and every draft is reviewed, edited, and approved by the clinician before it enters the chart. AI quality assurance checks charts for gaps before billing. We label roadmap items as roadmap — ask us in a demo and we will show you exactly what is available today.

    Next step

    See how DSL handles this on a walkthrough tailored to your agency.